Technical Analysis for AWH - Aspira Women's Health Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
20 DMA Support | Bullish | 0.00% | |
50 DMA Support | Bullish | 0.00% | |
Hammer Candlestick | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% |
Alert | Time |
---|---|
20 DMA Support | about 23 hours ago |
50 DMA Support | about 23 hours ago |
Up 3% | about 23 hours ago |
Down 2 % | about 23 hours ago |
Down 1% | about 23 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Aspira Women’s Health Inc. (formerly known as Vermillion, Inc. Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1®plus combines our FDA-cleared products OVA1® and OVERA® to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Our focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Oncology Healthcare Providers FDA Ovarian Cancer Genetic Testing Patient Management Analytical Solutions Gynaecological Cancer Gynaecology
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.65 |
52 Week Low | 0.738 |
Average Volume | 99,232 |
200-Day Moving Average | 2.33 |
50-Day Moving Average | 0.89 |
20-Day Moving Average | 0.88 |
10-Day Moving Average | 0.94 |
Average True Range | 0.11 |
RSI (14) | 50.25 |
ADX | 31.88 |
+DI | 25.18 |
-DI | 15.88 |
Chandelier Exit (Long, 3 ATRs) | 1.06 |
Chandelier Exit (Short, 3 ATRs) | 1.05 |
Upper Bollinger Bands | 1.04 |
Lower Bollinger Band | 0.71 |
Percent B (%b) | 0.56 |
BandWidth | 37.51 |
MACD Line | 0.01 |
MACD Signal Line | 0.01 |
MACD Histogram | 0.0044 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.00 | ||||
Resistance 3 (R3) | 1.00 | 0.96 | 0.98 | ||
Resistance 2 (R2) | 0.96 | 0.94 | 0.96 | 0.98 | |
Resistance 1 (R1) | 0.93 | 0.92 | 0.91 | 0.93 | 0.97 |
Pivot Point | 0.90 | 0.90 | 0.89 | 0.90 | 0.90 |
Support 1 (S1) | 0.87 | 0.87 | 0.85 | 0.87 | 0.83 |
Support 2 (S2) | 0.83 | 0.86 | 0.83 | 0.82 | |
Support 3 (S3) | 0.80 | 0.83 | 0.82 | ||
Support 4 (S4) | 0.80 |